- Quidel Corporation (NASDAQ:QDEL) announces that its non-prescription QuickVue At-Home OTC COVID-19 Test is now available in the U.S. for online delivery.
- “The ability to quickly order and receive the QuickVue At-Home tests and screen for COVID-19 in the privacy of their homes will give greater peace of mind to countless American families seeking a return to normal,” noted Douglas Bryant, CEO of Quidel.
- In March, the company announced the emergency use authorization received from the FDA for QuickVue At-Home COVID-19 Test allowing its prescription home use based on nasal swab specimens.
- This week, Lucira Health shares soared after announcing that its LUCIRA CHECK IT COVID-19 test kit would be available on Amazon.com in the US.